Binding to CD47, the SIRPα-Fc fusion protein can block the immunosuppressive CD47–SIRPα signal between macrophages and tumor cells as a decoy receptor and has demonstrated its immunotherapeutic efficacy in various tumors [1]. The gene discussed is SIRPA; the disease is neoplasm.